Collectively, these results indicate that inactivation of TLR4/MyD88-dependent signaling strongly inhibits development of atherosclerosis and promotes a more stable plaque phenotype, mainly by reducing inflammatory molecule release as a consequence of NF-κB inactivation. The gene discussed is NFKB1; the disease is atherosclerosis.